CompanyDrug

Jacobio Pharma Receives Approval for Phase I/IIa Study of LIF mAb in Advanced Solid Tumors

CompanyDrug

Nanjing Zenshine Pharmaceuticals’ ZX-7101A Meets Primary Endpoint in Phase II Influenza Study

Company

WuXi Advanced Therapies (WuXi ATU) Closes Manufacturing Facilities in Shanghai Due to Market Changes

CompanyDeals

Shenzhen Hepalink’s Subsidiary Techdow USA Secures Distribution Rights for ANDA-Approved Drug

Company

SPH CanSinoBio Suspends COVID-19 Vaccine Production for 180 Days Amid Market Shifts

CompanyDeals

CNBG and Sinopharm Form Partnership to Integrate Medical Industries

CompanyDeals

Beijing’s Surgerii Secures Series C3 Financing to Advance Endoscopic Surgical Robot Technology

CompanyDrug

Lynk Pharmaceuticals Concludes Phase I Study for JAK Inhibitor LNK01003 with Positive Results

CompanyDeals

BioNTech and Duality Biologics Ink Exclusive License Agreement for ADC Assets

R&D

China’s Life Expectancy on Track to Surpass 81.3 Years by 2035, Study Reveals

CompanyDeals

Willingmed Secures Series B Funding to Advance Clinical Infection Diagnostics

Policy / Regulatory

CDE Launches Guidelines to Expedite Pediatric and Rare Disease Drug Reviews